Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases. They are committed to transforming the treatment landscape for acid-related GI disorders, with a focus on a potassium-competitive acid blocker (PCAB). Phathom holds exclusive rights in the US, Europe, and Canada for their PCAB and aims to improve the lives of patients suffering from these conditions.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Website Highlights
🌟 Similar Trusted Businesses
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing oral antiviral therapies. They are dedicated to addressing unmet medical needs through innovative treatments for viral diseases. Their core focus is on the discovery, development, and commercialization of oral direct-acting antiviral therapies.
GTP BIOWAYS CDMO
OLON France is an expert CDMO serving the biopharmaceutical industry. They offer a wide range of services including process development, GMP manufacturing, and analytical development for biologics. Their expertise includes production in mammalian cells, microbial systems, and bioconjugates, positioning them as a versatile partner for drug development.